Vasoactive intestinal peptide: a novel neurotrophic factor

被引:5
|
作者
Gressens, P
机构
[1] Hop Robert Debre, Serv Neurol Pediat, F-75019 Paris, France
[2] Hop Robert Debre, INSERM, CRI 97 01, F-75019 Paris, France
来源
ARCHIVES DE PEDIATRIE | 1998年 / 5卷 / 06期
关键词
brain; developmental biology; receptors; sensory; vasoactive intestinal peptide;
D O I
10.1016/S0929-693X(98)80174-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide with potent growth-related actions on dissociated neural cells. In recent years its role in brain development was been elucidated: VIP has been shown to be a regulator of early neurodevelopment and embryonic growth, a stimulator of neocortical astrocytogenesis and a neuroprotective molecule against excitotoxic and other neurotoxic substances. Thus VIP appears as a fundamental regulator of brain growth and development, and a potent neuroprotective agent possibly involved in pathological processes such as microcephalies and some neurological impairments observed in very premature babies. Similarly, VIP and VIP derivatives could represent a new avenue in the search of therapeutics for excitotoxic lesions of the developing brain. (C) 1998, Elsevier, Paris.
引用
收藏
页码:654 / 660
页数:7
相关论文
共 50 条
  • [11] The role of vasoactive intestinal peptide in pulmonary diseases
    Zhong, Hong-Lin
    Li, Pei-Ze
    Li, Di
    Guan, Cha-Xiang
    Zhou, Yong
    LIFE SCIENCES, 2023, 332
  • [12] VASOACTIVE INTESTINAL PEPTIDE - CENTRAL AND PERIPHERAL EFFECTS
    Kalfin, R.
    Ivanova, M.
    Tashev, R.
    Belcheva, S.
    Belcheva, I.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S244 - S244
  • [13] VASOACTIVE-INTESTINAL-PEPTIDE IN THE HYPOTHALAMUS AND PITUITARY
    LAM, KSL
    NEUROENDOCRINOLOGY, 1991, 53 : 45 - 51
  • [14] Vasoactive intestinal peptide secreting tumour: An overview
    Una Cidon, Esther
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (04) : 808 - 819
  • [15] VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR SCINTIGRAPHY
    VIRGOLINI, I
    KURTARAN, A
    RADERER, M
    LEIMER, M
    ANGELBERGER, P
    HAVLIK, E
    LI, SR
    SCHEITHAUER, W
    NIEDERLE, B
    VALENT, P
    EICHLER, HG
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (10) : 1732 - 1739
  • [16] Vasoactive intestinal peptide and Parkinson's disease
    Kalfin, R. E.
    Lazarova, M. I.
    Mateeva, P. I.
    Yankova, L. M.
    Belcheva, S. P.
    Tashev, R. E.
    BULGARIAN CHEMICAL COMMUNICATIONS, 2017, 49 : 165 - 168
  • [17] Vasoactive intestinal peptide,a promising agent for myopia?
    Ayse Idil Cakmak
    Hikmet Basmak
    Huseyin Gursoy
    Mete Ozkurt
    Nilgun Yildirim
    Nilufer Erkasap
    Mustafa Deger Bilgec
    Nese Tuncel
    Ertugrul Colak
    International Journal of Ophthalmology, 2017, (02) : 211 - 216
  • [18] Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide
    Voice, JK
    Dorsam, G
    Chan, RC
    Grinninger, C
    Kong, Y
    Goetzl, EJ
    REGULATORY PEPTIDES, 2002, 109 (1-3) : 199 - 208
  • [19] Effect of vasoactive intestinal peptide on gastric adenocarcinoma
    Li, Guo-Hua
    Qian, Wei
    Song, Geng-Qing
    Hou, Xiao-Hua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) : 1328 - 1335
  • [20] Vasoactive intestinal peptide, a promising agent for myopia?
    Cakmak, Ayse Idil
    Basmak, Hikmet
    Gursoy, Huseyin
    Ozkurt, Mete
    Yildirim, Nilgun
    Erkasap, Nilufer
    Bilgec, Mustafa Deger
    Tuncel, Nese
    Colak, Ertugrul
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (02) : 211 - 216